Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cirino

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Biochemical Pharmacology|February 4, 1998
Multiple controls in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthaseG Cirino
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2003
Nitric oxide releasing drugs: from bench to bedsideG Cirino
Journal of Lipid Mediators|October 1, 1993
Human recombinant lipocortin 1 (annexin 1) has anticoagulant activity on human plasma in vitroG Cirino, C Cicala
General Pharmacology|September 1, 1993
Phospholipase A2-induced hypotension in the rat and its pharmacological modulationC Cicala, G Cirino
Life Sciences|May 26, 1998
Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalkC Cicala, G Cirino
Agents and Actions|August 1, 1986
Phospholipase inhibition and prostacyclin generation by gastric muscularis and mucosa layersG Cirino, L Sorrentino
Canadian Journal of Physiology and Pharmacology|January 1, 1989
A superfusion bioassay for platelet-activating factorG Cirino, J L Wallace
Prostaglandins|July 1, 1987
Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitroG Cirino, R J Flower
Trends in Pharmacological Sciences|November 1, 1994
The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugsJ L Wallace, G Cirino
Pharmacology & Therapeutics|May 5, 2001
Pharmacological modulation, preclinical studies, and new clinical features of myocardial ischemic preconditioningC Napoli, A Pinto, G Cirino
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Biochemical Pharmacology|February 4, 1998
Multiple controls in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthaseG Cirino
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2003
Nitric oxide releasing drugs: from bench to bedsideG Cirino
Journal of Lipid Mediators|October 1, 1993
Human recombinant lipocortin 1 (annexin 1) has anticoagulant activity on human plasma in vitroG Cirino, C Cicala
General Pharmacology|September 1, 1993
Phospholipase A2-induced hypotension in the rat and its pharmacological modulationC Cicala, G Cirino
Life Sciences|May 26, 1998
Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalkC Cicala, G Cirino
Agents and Actions|August 1, 1986
Phospholipase inhibition and prostacyclin generation by gastric muscularis and mucosa layersG Cirino, L Sorrentino
Canadian Journal of Physiology and Pharmacology|January 1, 1989
A superfusion bioassay for platelet-activating factorG Cirino, J L Wallace
Prostaglandins|July 1, 1987
Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitroG Cirino, R J Flower
Trends in Pharmacological Sciences|November 1, 1994
The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugsJ L Wallace, G Cirino
Pharmacology & Therapeutics|May 5, 2001
Pharmacological modulation, preclinical studies, and new clinical features of myocardial ischemic preconditioningC Napoli, A Pinto, G Cirino
Pageof 16